Catalyst Pharmaceuticals Inc
CPRX
Market Cap$2.97B
Close$
$16.80
31.1% downside
Current Fair Value
31.1% downsideOvervalued by 31.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.97 Billion |
|---|---|
| Enterprise Value | $2.41 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.38 |
| Beta | 0.7 |
| Outstanding Shares | 121,472,468 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 15 |
|---|---|
| PEG | -6.18 |
| Price to Sales | 8.12 |
| Price to Book Ratio | 4.06 |
| Enterprise Value to Revenue | 5.25 |
| Enterprise Value to EBIT | 13.83 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany